You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TVTX Sale Disclosure
Heerma Peter · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$93.46K
Heerma Peter EVP, Chief Commercial Officer
TVTX
Travere Therapeutics
TVTX
Transaction date
Sep 15, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 2 days later
TVTX daily price context
Close on/before transaction
$62.51
Sep 15, 2026
First close after public filing
$62.76
Sep 18, 2026
30-day return after filing
-19.55%
Through Oct 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,431 shares @ $65.31
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001789617-26-000004
Filing cohort
Transactions in this filing
Showing 15 of 21
Trades
21
Issuers
1
Estimated value
$21.91M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 17, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 17, 2026 | $538.92K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 17, 2026 | $185.52K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $850.3K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $476.23K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 16, 2026 | $5.04M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $1.13M |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 16, 2026 | $5.92M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $30.93K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $1.06M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |